Status:

COMPLETED

Genetic Determinants of the Coronary Microvascular Obstruction in PCI

Lead Sponsor:

Privolzhsky Research Medical University

Conditions:

Myocardial Infarction

No-Reflow Phenomenon

Eligibility:

All Genders

18+ years

Brief Summary

Myocardial infarction (MI) remains one of the most common causes of death. Percutaneous coronary intervention (PCI) is the main treatment option to restore blood flow through the infarction-related co...

Detailed Description

The aim of the study to identify the genetic determinants of the coronary microvascular obstruction development during percutaneous coronary interventions in myocardial infarction patients. The study ...

Eligibility Criteria

Inclusion

  • informed consent to participate in the study;
  • male or female 18 years of age or older;
  • type 1 ST-segment elevation MI (according to the criteria of the fourth universal definition of myocardial infarction and current clinical guidelines);
  • blood sampling in the operating room (immediately after PCI) and signing the informed consent;
  • for the "CMVO+" group: CMVO because of PCI (CMVO is registered according to the criteria from the European Society of Cardiology clinical guidelines);
  • for the "CMVO-" group: absence of CMVO after PCI; patient should compliance by sex and age (±5 years) with pair in the "CMVO+" group.

Exclusion

  • late admission (more than 48 hours from the onset of anginal pain) or early post-infarction angina pectoris;
  • not 1 type MI;
  • complications during PCI (dissection, perforation or acute intraoperative thrombosis of the IRA);
  • death during PCI, not due to the CMVO development;
  • concomitant terminal pathology (not associated with MI) with a life expectancy less than 1 month.

Key Trial Info

Start Date :

April 11 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 25 2023

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT05355532

Start Date

April 11 2022

End Date

March 25 2023

Last Update

September 25 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

City Clinical Hospital No. 13 of the Avtozavodsky District of Nizhny Novgorod

Nizhny Novgorod, Nizhny Novgorod Oblast, Russia, 603018

2

Central Research Laboratory of the Privolzhsky Research Medical University

Nizhny Novgorod, Nizhny Novgorod Oblast, Russia, 603104